Historically, survival rates for mesothelioma are measured in terms of one-year survival. However, many mesothelioma patients are beating the odds and living far beyond median survival rates thanks to advances in treatment.
Additionally, five-year survival for mesothelioma patients has steadily improved since 1999, according to the latest report from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program.
Long-term survivors attribute their success to a multidisciplinary approach to treatment from mesothelioma specialists, alternative medicine, clinical trials and nutritional changes.
Mesothelioma Survival Rate vs. Life Expectancy
While these terms are often used interchangeably, mesothelioma life expectancy and survival rates carry different meanings.
Life expectancy refers to the average age a person is expected to live based on the year they were born, where they were born and other demographic factors. An aggressive cancer, such as mesothelioma, can shorten this average.
Survival rates come into play after a person is diagnosed with cancer or another serious health condition. These rates show the percentage of patients in a study or treatment group who are still alive for a certain period of time following a diagnosis.
Researchers describe the mesothelioma survival rate in several ways — usually six-month and one-year survival, but also the percentage of patients who live two years, three years and five years.
Mesothelioma has no definitive cure and most cases are diagnosed in the latter stages, after tumors have spread — a main reason why survival rates are generally lower compared to other cancers.
Factors That Affect Survival Rate
Survival rates for mesothelioma cancer vary by the patient’s age, gender, race and several other factors. The location, stage and cell type of the cancer, as well as your overall health, have the strongest influence on your mesothelioma prognosis.
Age
Overall, older mesothelioma patients have a much lower survival rate than younger ones. More than 55 percent of patients diagnosed before the age of 50 live one year, but less than 30 percent of patients 75 or older live the same amount of time.
This difference is largely because younger patients are eligible for more intensive treatments such as surgery. Older individuals may not be candidates for these procedures because of poor overall health or a high risk of complications.
Rates are similar for long-term survival. Patients diagnosed before age 50 have nearly a 25 percent chance of surviving a decade, while that drops sharply — to 5.4 percent — for patients between the ages of 50 and 64.
However, it is rare for someone younger than 50 to be diagnosed with mesothelioma. The average age at diagnosis is 69.
The five-year survival rate for patients diagnosed between ages 65-74 is 6.7 percent. That rate falls to 3.8 percent for those 75 or older.
Gender
Research shows women with mesothelioma experience nearly three-fold better survival rate compared to men. After analyzing mesothelioma cases reported in the National Cancer Institute’s SEER database from 1988 to 2013, researchers found the overall five-year survival rate for men was 7 percent, compared with 15 percent for women.
Most asbestos exposure occurs in the workplace, particularly in industrial jobs traditionally held by men. That helps explain why men account for the majority of all mesothelioma cases.
When asbestos use was far more pervasive decades ago, the few women who did develop a related illness were usually exposed because they lived near mines or factories — especially those that processed the mineral. Women also found themselves exposed by spouses, family members or friends who worked around asbestos and brought home the tiny fibers on their clothes.
Although numerous factors contribute to patient survival, women with mesothelioma appear to survive longer than men regardless of age, cancer stage, race or type of treatment. For every age group studied in the SEER program, women fared significantly better than men.
There is currently no conclusive answer as to why, but some researchers believe the improved survival could be explained by hormonal differences between genders.
Women are also more likely to be diagnosed with peritoneal mesothelioma, which carries a better prognosis compared to the more common pleural type.